[Experiences gained in the treatment of oto- and rhinogenic meningitides, 1965-1975 (author's transl)].
The studies permit the conclusion that morbidity and mortality due to purulent oto- or rhinogenic meningitides have not essentially changed over the past eleven years despite antibiotics that are more effective and can be given in higher doses than so far. Resistent strains of bacteria, allergies and insufficient antibiotic therapy are probable causes for that fact. Under certain circumstances a sufficient and specific antibiotic therapy may delay surgical intervention or make it even unnecessary. Advanced age and additional diseases seem neither to influence operability nor to increase morbidity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004427:Ear Diseases / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D009668:Nose Diseases / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents
Erfahrungen bei der Behandlung oto- und rhinogener Meningitiden: 1965-1975